NDC 49884-985

Nateglinide

Nateglinide

Nateglinide is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Nateglinide.

Product ID49884-985_20d37769-1721-4531-88cf-e29082373c71
NDC49884-985
Product TypeHuman Prescription Drug
Proprietary NameNateglinide
Generic NameNateglinide
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2009-09-08
Marketing End Date2023-11-30
Marketing CategoryANDA / ANDA
Application NumberANDA077463
Labeler NamePar Pharmaceutical, Inc.
Substance NameNATEGLINIDE
Active Ingredient Strength120 mg/1
Pharm ClassesGlinide [EPC], Potassium Channel Antagonists [MoA]
NDC Exclude FlagN

Packaging

NDC 49884-985-01

100 TABLET, COATED in 1 BOTTLE, PLASTIC (49884-985-01)
Marketing Start Date2009-09-08
Marketing End Date2023-11-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49884-985-05 [49884098505]

Nateglinide TABLET, COATED
Marketing CategoryANDA
Application NumberANDA077463
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-08
Marketing End Date2017-08-10

NDC 49884-985-10 [49884098510]

Nateglinide TABLET, COATED
Marketing CategoryANDA
Application NumberANDA077463
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-08
Marketing End Date2017-08-10

NDC 49884-985-01 [49884098501]

Nateglinide TABLET, COATED
Marketing CategoryANDA
Application NumberANDA077463
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-08

Drug Details

Active Ingredients

IngredientStrength
NATEGLINIDE120 mg/1

OpenFDA Data

SPL SET ID:c8ab95a2-82e6-473a-aff3-291306997db6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311919
  • 314142
  • Pharmacological Class

    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]
    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]

    Medicade Reported Pricing

    49884098501 NATEGLINIDE 120 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Nateglinide" or generic name "Nateglinide"

    NDCBrand NameGeneric Name
    0591-3354NateglinideNateglinide
    0591-3355NateglinideNateglinide
    0615-7585NateglinideNateglinide
    0615-7586NateglinideNateglinide
    16571-758NATEGLINIDENATEGLINIDE
    16571-759NATEGLINIDENATEGLINIDE
    42291-636NateglinideNateglinide
    42291-637NateglinideNateglinide
    49884-984NateglinideNateglinide
    49884-985NateglinideNateglinide
    51407-656Nateglinidenateglinide
    51407-657Nateglinidenateglinide
    52536-063NateglinideNateglinide
    52536-067NateglinideNateglinide
    55111-328NateglinideNateglinide
    55111-329NateglinideNateglinide
    60429-434NateglinideNateglinide
    60429-435NateglinideNateglinide
    60687-673Nateglinidenateglinide
    60687-684Nateglinidenateglinide
    64380-167Nateglinidenateglinide
    64380-168Nateglinidenateglinide
    68084-458NateglinideNateglinide
    68084-459NateglinideNateglinide
    68382-721NateglinideNateglinide
    68382-722NateglinideNateglinide
    70771-1016NateglinideNateglinide
    70771-1015NateglinideNateglinide
    71209-030NateglinideNateglinide
    71209-031NateglinideNateglinide
    75834-205NATEGLINIDENATEGLINIDE
    75834-206NATEGLINIDENATEGLINIDE
    0078-0351Starlixnateglinide
    0078-0352Starlixnateglinide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.